Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat

Journal of Neurochemistry

Volumn 70, Issue 2, 1998, Pages 794-805

  Brouillet, Emmanuel ^a   Guyot, Marie Caroline ^a   Mittoux, Vincent ^a   Altairac, Séverine ^a   Condé, Françoise ^a   Palfi, Stéphane ^a   Hantraye, Philippe ^a  

^a SERVICE HOSPITALIER FRÉDÉRIC JOLIOT   (France)

Author keywords

Excitotoxicity; Huntington's disease; Mitochondria; Neuronal death; Striatum; Succinate dehydrogenase

Indexed keywords

3 NITROPROPIONIC ACID; SUCCINATE DEHYDROGENASE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN DEGENERATION; CORPUS STRIATUM; ENZYME INHIBITION; HUNTINGTON CHOREA; MALE; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; RESPIRATORY CHAIN;

ANIMALIA;

EID: 0031914584     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.70020794.x     Document Type: Article

References (37)

1. Ackrell B. A., Kearney E. B., and Singer T. P. (1978) Mammalian succinate dehydrogenase. Methods Enzymol. 53, 466-483.
2. Albin R. L. and Greenamyre J. T. (1992) Alternative excitotoxic hypotheses. Neurology 42, 733-738.
3. Alston T. A., Mela L., and Bright H. J. (1977) Nitropropionate, the toxic substance of Indigofera, is a suicide inactivator of succinate dehydrogenase. Proc. Natl. Acad. Sci. USA 74, 3767-3771.
4. Beal M. F. (1992) Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illness? Ann. Neurol. 31, 119-130.
5. Beal M. F., Brouillet E., Jenkins B., Ferrante R. J., Kowall N. W., Miller J. M., Storey E., Srivastava R., Rosen B. R., and Hyman B. T. (1993) Neurochemical and histological characterization of the striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J. Neurosci. 13, 1481-1492.
6. Brennan W. A., Bird E. D., and Aprille J. R. (1985) Regional mitochondrial respiratory activity in Huntington's disease brain. J. Neurochem. 44, 1948-1950.
7. Brouillet E., Jenkins B. G., Hyman B. T., Ferrante R. J., Kowall N. W., Srivastava R., Roy D. S., Rosen B. R., and Beal M. F. (1993) Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid. J. Neurochem. 60, 356-359.
8. Brouillet E., Hyman B. T., Jenkins B., Henshaw R., Shulz J. B., Sodhi P., Rosen B., and Beal M. F. (1994) Systemic or local administration of azide produces striatal lesions by an energy impairment-induced excitotoxic mechanism. Exp. Neurol. 129, 175-182.
9. Brouillet E., Hantraye P., Ferrante R. J., Dolan R., Leroy-Willig A., Kowall N. W., and Beal M. F. (1995) Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. Proc. Natl. Acad. Sci. USA 92, 7105-7109.
10. Browne S. E., Bowling A. C., MacGarvey U., Baik M. J., Berger S. C., Muqit M. K., Bird E. D., and Beal M. F. (1997) Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann. Neurol. 41, 646-653.
11. Coles C. J., Edmonson D. E., and Singer T. P. (1979) Inactivation of succinate dehydrogenase by 3-nitropropionate. J. Biol. Chem. 255, 4772-4780.
12. Fink S. L., Ho D. Y., and Sapolsky R. M. (1996) Energy and glutamate dependency of 3-nitropropionic acid neurotoxicity in culture. Exp. Neurol. 138, 298-304.
13. Gould D. H., Wilson M. P., and Hamar D. W. (1985) Brain enzyme and clinical alterations induced in rats and mice by nitroaliphatic toxicants. Toxicol. Lett. 27, 83-89.
14. Greene J. G. and Greenamyre J. T. (1995) Characterization of the excitotoxic potential of the reversible succinate dehydrogenase inhibitor malonate. J. Neurochem. 64, 430-436.
15. Gu M., Gash M. T., Mann V. M., Javoy-Agid F., Cooper J. M., and Shapira A. H. (1996) Mitochondrial defect in Huntington's disease caudate nucleus. Ann. Neurol. 39, 385-389.
16. Guyot M.-C., Hantraye P., Dolan R., Palfi S., Mazière M., and Brouillet E. (1997a) Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid. Neuroscience 79, 45-56.
17. Guyot M.-C., Palfi S., Stutzmann J. M., Mazière M., Hantraye P., and Brouillet E. (1997b) Riluzole protects from motor deficits and striatal degeneration produced by systemic 3-nitropropionic acid intoxication in rats. Neuroscience 81, 141-149.
18. Hamilton B. F. and Gould D. H. (1987a) Correlation of morphological brain lesions with physiological alterations and blood-brain barrier impairment by 3-nitropropionic acid toxicity in rats. Acta Neuropathol. (Berl.) 74, 67-74.
19. Hamilton B. F. and Gould D. H. (1987b) Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: a type of hypoxic (energy deficient) brain damage. Acta Neuropathol. (Berl.) 72, 286-297.
20. Jenkins B. G., Koroshetz W. J., Beal M. F., and Rosen R. (1993) Evidence for an energy metabolic defect in Huntington's disease using localized proton spectroscopy. Neurology 43, 2689-2693.
21. Koutouzis T. K., Borlongan C. V., Scorcia T., Creese I., Cahill D. W., Freeman T. B., and Sanberg P. R. (1994) Systemic 3-nitropropionic acid: long-term effects on locomotor behavior. Brain Res. 646, 242-246.
22. Kugler P., Weeger T., and Horvath E. (1995) Glutamate dehydrogenase in astrocytes of the rat dentate gyrus following lesion of the entorhinal cortex. Neuroscience 64, 173-182.
23. Kuwert T., Lange H. W., Langen K.-J., Herzog H., Aulich A., and Feinendegen L. E. (1990) Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease. Brain 113, 1405-1423.
24. Ludolph A. C., He F., Spencer P. S., Hammerstad J., and Sabri M. (1991) 3-Nitropropionic acid - exogenous animal neurotoxin and possible human striatal toxin. Can. J. Neurol. Sci. 18, 492-498.
25. Majak W. and McDiarmid R. E. (1990) Detection and quantitative determination of 3-nitropropionic acid in bovine urine. Toxicol. Lett. 50, 213-220.
26. Mann V. M., Cooper J. M., Javoy-Agid F., Agid Y., Jenner P., and Schapira A. H. V. (1990) Mitochondrial function and parental sex effect in Huntington's disease. Lancet 336, 749.
27. Martin J. J., Van de Vyver F. L., Scholte H. R., Roodhooft A. M., Ceuterick C., Martin L., and Luyt-Houwen I. E. M. (1988) Defect in succinate oxidation by isolated muscle mitochondria in a patient with symmetrical lesions in the basal ganglia. J. Neurol. Sci. 84, 189-200.
28. Mazziotta J. C., Phelps M. E., Pahl J. J., Huang S. C., Baxter L. R., Riege W. H., Hoffmann J. M., Kuhl D. E., Lanto A. B., Wapenski J. A., and Markham C. H. (1987) Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease. N. Engl. J. Med. 316, 356-362.
29. Nishino H., Shimano Y., Kumazaki M., and Sakurai T. (1995) Chronically administered 3-nitropropionic acid induces striatal lesions attributed to dysfunction of the blood-brain barrier. Neurosci. Lett. 186, 161-164.
30. Palfi S., Ferrante R. J., Brouillet E., Beal M. F., Dolan R., Guyot M.-C., Peschanski M., and Hantraye P. (1996) Chronic treatment in baboons replicates the cognitive and motor deficits of Huntington's disease. J. Neurosci. 16, 3019-3025.
31. Pang Z. and Geddes J. W. (1997) Mechanisms of cell death induced by the mitochondrial toxin 3-nitropropionic acid: acute excitotoxic necrosis and delayed apoptosis. J. Neurosci. 17, 3064-3073.
32. Riddle D., Richards A., Zsuppan F., and Purves D. (1992) Growth of the rat somatic sensory cortex and its constituent parts during postnatal development. J. Neurosci. 12, 3509-3524.
33. Sharp A. H. and Ross A. R. (1996) Neurobiology of Huntington's disease. Neurobiol. Dis. 3, 3-15.
34. Simpson J. R. and Isacson O. (1993) Mitochondrial impairment reduces the threshold for in vivo NMDA-mediated neuronal death in the striatum. Exp. Neurol. 121, 57-64.
35. Weller M. and Paul S. M. (1993) 3-Nitropropionic acid is an indirect excitotoxin to cultured cerebellar granule neurons. Eur. J. Pharmacol. 248, 223-228.
36. Wüllner U., Young A. B., Penney J. B., and Beal M. F. (1994) 3-Nitropropionic acid toxicity in the striatum. J. Neurochem. 63, 1772-1781.
37. Zeevalk G. D., Derr-Yellin E., and Nicklas W. J. (1995) NMDA receptor involvement in toxicity to dopamine neurons in vitro caused by the succinate dehydrogenase inhibitor 3-nitropropionic acid. J. Neurochem. 64, 455-458.